Ralf Kircheis

Ralf Kircheis

UNVERIFIED PROFILE

Are you Ralf Kircheis?   Register this Author

Register author
Ralf Kircheis

Ralf Kircheis

Publications by authors named "Ralf Kircheis"

Are you Ralf Kircheis?   Register this Author

21Publications

157Reads

7Profile Views

Low-Cost Microwave-Assisted Partial Pseudomorphic Transformation of Biogenic Silica.

Front Chem 2019 13;7:575. Epub 2019 Aug 13.

Institute of Chemical Technology, Universität Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fchem.2019.00575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705224PMC
August 2019

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Antiviral Res 2011 Sep 13;91(3):304-13. Epub 2011 Jul 13.

Friedrich-Loeffler-Institut, Institute of Immunology, Paul-Ehrlich Str. 28, 72076 Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2011.07.006DOI Listing
September 2011

Immunogenicity of therapeutics: a matter of efficacy and safety.

Expert Opin Drug Discov 2010 Nov 1;5(11):1067-79. Epub 2010 Sep 1.

Vela pharmazeutische Entwicklung und Laboranalytik GmbH, Brunnerstrasse 59, 1230, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17460441.2010.514326DOI Listing
November 2010

In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157).

Pharmaceuticals (Basel) 2010 Jun 10;3(6):1887-1891. Epub 2010 Jun 10.

Meridian Biopharmaceuticals GmbH, Brunnerstrasse 59, 1230 Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph3061887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033957PMC
June 2010

Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences.

Biomark Insights 2008 Apr 18;3:227-235. Epub 2008 Apr 18.

Vela Laboratories GmbH, Brunner Strasse 69/Obj. 3, 1230 Wien, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688352PMC
April 2008

Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function.

J Chromatogr B Analyt Technol Biomed Life Sci 2007 Jun 26;852(1-2):250-6. Epub 2007 Jan 26.

Igeneon Immunotherapy of Cancer, Brunner Strasse 69/3, 1230 Vienna, Austria.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S157002320700066
Publisher Site
http://dx.doi.org/10.1016/j.jchromb.2007.01.024DOI Listing
June 2007

Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen.

J Pharmacol Exp Ther 2006 Dec 8;319(3):1459-66. Epub 2006 Sep 8.

Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Waehringer Str. 13a, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.106.107318DOI Listing
December 2006

Cancer immunotherapy.

Biotechnol J 2006 Feb;1(2):138-47

Apeiron Biologics Forschungs- und Entwicklungs-GmbH, Brunnerstrasse 59, 1230 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/biot.200500044DOI Listing
February 2006

EpCAM is not a LAIR-1 ligand!

Cancer Biol Ther 2005 Apr 9;4(4):357; author reply 358. Epub 2005 Apr 9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.4.4.1661DOI Listing
April 2005

Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.

Biomed Pharmacother 2004 Apr;58(3):152-61

Pharmaceutical Biology-Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2004.01.003DOI Listing
April 2004

Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes.

J Control Release 2003 Aug;91(1-2):173-81

Pharmaceutical Biology-Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universitaet, Butenandtstr. 5-13, D-81377, Muenchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0168-3659(03)00230-xDOI Listing
August 2003

Technology evaluation: TNFerade, GenVec.

Curr Opin Mol Ther 2003 Aug;5(4):437-47

Igeneon Immunotherapy of Cancer, Brunner Strasse 69/3, A-1230 Vienna, Austria.

View Article

Download full-text PDF

Source
August 2003

Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.

Bioconjug Chem 2003 Jan-Feb;14(1):222-31

Pharmaceutical Biology-Biotechnology, Department for Pharmacy, Ludwig-Maximilians-Universitaet, Butenandtstrasse 5-13, D-81377 Muenchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bc0256087DOI Listing
July 2003